hyaluronoglucosaminidase has been researched along with Breast Cancer in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.62) | 18.7374 |
1990's | 4 (6.90) | 18.2507 |
2000's | 14 (24.14) | 29.6817 |
2010's | 21 (36.21) | 24.3611 |
2020's | 14 (24.14) | 2.80 |
Authors | Studies |
---|---|
Chennathukuzhi, VM; Cloud, AS; Ganeshkumar, S; Gunewardena, S; Jensen, RA; Kumaraswamy, E; Shimak, RM; Vargheese, AM | 1 |
Carvalho, AM; Gomes, M; Novoa-Carballal, R; Pashkuleva, I; Reis, RL; Soares da Costa, D; Valcarcel, J; Vázquez, JA | 1 |
Chen, M; Ge, X; Liu, J; Ma, Q; Tang, Y; Wen, Q; Zhang, L; Zhao, M; Zhu, L | 1 |
Duco, MR; Murdock, JL; Reeves, DJ | 1 |
Chen, W; He, J; Hsieh, IY; Li, F; Li, J; Liang, Z; Lin, B; Lu, B; Lu, G; Lv, W; Wang, L; Zhao, W | 1 |
Chen, H; Cui, S; Du, J; Fan, X; Lan, H; Zhang, E; Zhang, S; Zhang, Z; Zhao, Y; Zhen, Y; Zhi, D | 1 |
Chen, Y; Li, L; Zhang, J | 1 |
Abukhdeir, AM; Amiri-Kordestani, L; Beaver, JA; Bhatnagar, V; Bloomquist, EW; Chiu, HJ; Gao, JJ; Ghosh, S; Gong, Y; Hou, S; Jiang, X; Kluetz, PG; Osgood, CL; Pazdur, R; Philip, R; Pierce, WF; Qiu, J; Rahman, NA; Ricks, TK; Rizvi, F; Seidman, J; Song, P; Wilson, W; Yu, J; Zhang, H | 1 |
Badovinac Crnjevic, T; Colomer, R; De Laurentiis, M; Heeson, S; Hogea, A; Im, SA; Jackisch, C; Jung, KH; Kirschbrown, WP; Mattar, A; Nowecki, Z; Pierga, JY; Restuccia, E; Schem, C; Shivhare, M; Stroyakovskii, D; Tan, AR | 1 |
Brundel, DH; Feeney, OM; Gracia, G; Kaminskas, LM; Kang, DW; McIntosh, MM; Nowell, CJ; Porter, CJ; Suys, EJ | 1 |
Li, H; Rong, J; Yang, Y; Zhao, J; Zhou, F; Zhuang, S | 1 |
Chen, H; Han, L; Ju, X; Miao, T; Ni, J | 1 |
Baldovino, S; Radin, M; Roccatello, D; Sciascia, S | 1 |
Du, J; Hua, Z; Jiao, M; Ju, C; Wang, Q; Xie, D; Xue, L; Zhang, C; Zhou, A | 1 |
Gao, H; He, X; Liu, R; Qin, L; Xiao, W; Xie, R; Yang, X; Yang, Z; Yu, W | 1 |
Bahou, WF; Cao, J; Dufour, A; Evensen, NA; Hu, YJ; Kadam, P; Kuscu, C; Nguyen, HL; Pulkoski-Gross, A; Zarrabi, K; Zucker, S | 1 |
Ding, SJ; Dong, J; Fu, K; Geng, L; Hassan, H; Hou, J; Huang, X; Jami, MS; Li, Y; Liu, M; Peng, H; Singh, RK; Varney, ML; Wang, J; Yu, F | 1 |
Bartram, CR; Brenner, H; Bugert, P; Burwinkel, B; Claus, R; Cuk, K; Engel, C; Hoth, M; Marme, F; Pfütze, K; Plass, C; Qu, B; Schmutzler, R; Schneeweiss, A; Schott, S; Sohn, C; Sutter, C; Wappenschmidt, B; Yang, R; Zucknick, M | 1 |
Schmaus, A; Sleeman, JP | 1 |
Cao, M; Du, Y; Gao, F; He, Y; Liu, Y; Wang, W; Wu, M; Yang, C | 1 |
Bomba, HN; Gu, Z; Hu, Q; Isaacson, AJ; Jiang, T; Lu, Y; Sun, W; Ye, Y | 1 |
Benhadjeba, S; Carmona, E; Edjekouane, L; Fleury, H; Gévry, N; Jangal, M; Tremblay, A | 1 |
Hadrian, R; Palmes, D | 1 |
Laakmann, E; Marx, AK; Matschke, J; Milde-Langosch, K; Müller, V; Oliveira-Ferrer, L; Prehm, P; Schmalfeldt, B; Schumacher, U; Stürken, C; Wikman, H; Witzel, I | 1 |
Acharya, A; Chen, XB; Guo, K; Hou, XL; Li, CF; Lin, FH; Nie, Y; Qiao, SP; Shi, SL; Tian, WM; Yao, LF; Zhao, YF | 1 |
Feng, L; Gao, R; Gopalakrishnakone, P | 1 |
Delpech, B; Ren, GS; Tan, JX; Vasse, M; Wang, XY | 1 |
Li, HY; Ran, L; Ren, GS; Su, XL; Tan, JX; Wang, L; Wang, XY; Zheng, K | 1 |
Bao, JJ; Fang, CH; Wu, WD; Yang, ZX | 1 |
Deivanayagam, C; Kumar, S; Lee, JH; Moore, LD; Ponnazhagan, S; Pritchard, DG | 1 |
Bernaciak, M; Bryś, M; Forma, E; Krześlak, A; Romanowicz, H | 1 |
Li, HY; Ren, GS; Shi, Y; Su, XL; Tan, JX; Wang, L; Wang, XY | 1 |
Cao, J; Evensen, N; Hu, YJ; Kim, D; Kuscu, C; Zucker, S | 1 |
Banerjee, SD; Kollapalli, SP; Mortha, KK; Srinivas, P; Thomas, A | 1 |
LACASSAGNE, A; LOISELEUR, J; RUDALI, G | 2 |
Bourguignon, LY; Diedrich, F; Gilad, E; Singleton, PA; Stern, R | 1 |
Chen, JG; Ding, HY; Ning, HY; Underhill, CB; Wang, LP; Xu, XM; Yang, SM; Yu, JY; Zhang, LR | 1 |
Brown, TJ; Brownlee, GR; Nilsson, SK; Udabage, L | 1 |
Barrett, JC; Garcés, G; Horikawa, I; Michishita, E | 1 |
Chen, J; Ding, I; Gao, F; Han, Z; Kim, S; Liu, W; Okunieff, P; Underhill, CB; Wang, L; Yang, S; Zhang, J; Zhang, L | 1 |
Li, XT; Ran, L; Ren, GS; Tan, JX; Tu, G; Wang, XY | 1 |
Brown, TJ; Heldin, P; Li, L; Li, Y | 1 |
BITTNER, JJ; GLICK, D; GOOD, TA | 1 |
Abraham, J; Bonney, G; Dewitty, RL; Lokeshwar, VB; Marshalleck, JJ; Poola, I; Yue, Q | 1 |
Nishi, T; Saya, H; Tanabe, KK | 1 |
Bertrand, P; Chauzy, C; d'Anjou, J; Delpech, B; Duval, C; Girard, N; Ménard, JF | 1 |
Bormann, G; Fischer, M; Marsch, WC; Wohlrab, J | 1 |
Bader, A; Egger, G; Glasner, A; Pfragner, R; Siegl, V; Steindorfer, P; Zatloukal, K | 1 |
Barry, E; Box, G; Eccles, S; McKenzie, E; Page, MJ; Patel, S; Rohlff, CR; Stamps, A; Stubberfield, C; Terrett, J; Turner, PR; Tyson, K; Young, K | 1 |
Beech, DJ; Deng, N; Madan, AK | 1 |
Gao, F; Underhill, CB; Zhang, L | 1 |
Azzopardi, JG; Gad, A | 1 |
Koláŏvá, M | 1 |
Bannke, S; Beckenlehner, K; Bernhardt, G; Schiess, W; Schönenberg, H; Spruss, T | 1 |
3 review(s) available for hyaluronoglucosaminidase and Breast Cancer
Article | Year |
---|---|
Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Disease-Free Survival; Female; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Injections, Subcutaneous; Middle Aged; Receptor, ErbB-2; Trastuzumab | 2020 |
In brief: Phesgo - a fixed-dose combination for HER-2 positive breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Drug Combinations; Female; Humans; Hyaluronoglucosaminidase; Neoadjuvant Therapy; Receptor, ErbB-2; Trastuzumab | 2021 |
Animal Models of Secondary Lymphedema: New Approaches in the Search for Therapeutic Options.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Cytokines; Disease Models, Animal; Female; Haplorhini; Humans; Hyaluronoglucosaminidase; Intercellular Signaling Peptides and Proteins; Lymphatic Vessels; Lymphedema; Lymphography; Lymphoscintigraphy; Molecular Targeted Therapy; Rabbits; Rodentia; Sheep; Stem Cells; Surgical Procedures, Operative; Swine; Vascular Endothelial Growth Factor C | 2017 |
1 trial(s) available for hyaluronoglucosaminidase and Breast Cancer
Article | Year |
---|---|
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Receptor, ErbB-2; Time Factors; Trastuzumab; Treatment Outcome | 2021 |
54 other study(ies) available for hyaluronoglucosaminidase and Breast Cancer
Article | Year |
---|---|
Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression.
Topics: Biomarkers, Tumor; Breast Neoplasms; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Loss of Function Mutation; Matrix Metalloproteinases, Membrane-Associated; MCF-7 Cells; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Processes; Phenotype; Prognosis; Repressor Proteins; RNA, Messenger; Signal Transduction; Up-Regulation | 2022 |
Hyaluronan Brush-like Copolymers Promote CD44 Declustering in Breast Cancer Cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Methacrylates; Oximes; Polymers | 2022 |
Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer.
Topics: Animals; Breast Neoplasms; Coloring Agents; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Trastuzumab | 2022 |
H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.
Topics: Animals; Benzazepines; Biomarkers, Tumor; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Histones; Humans; Hyaluronoglucosaminidase; Mice; Mice, Nude; Prognosis; Pyrimidines; RNA, Messenger | 2020 |
Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Gene Transfer Techniques; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Liposomes; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Polysaccharides; RNA, Small Interfering; Survivin; Xenograft Model Antitumor Assays | 2020 |
Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Hyaluronoglucosaminidase; Neoplasm Invasiveness; Signal Transduction; STAT3 Transcription Factor | 2021 |
Pertuzumab, Trastuzumab and Hyaluronidase-zzxf.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiomyopathies; Female; Fetal Diseases; Humans; Hyaluronoglucosaminidase; Lung Diseases; Pregnancy; Trastuzumab | 2020 |
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Approval; Female; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Middle Aged; Multicenter Studies as Topic; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Trastuzumab; Treatment Outcome; United States; United States Food and Drug Administration | 2021 |
Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Nanoparticles; Polyethylene Glycols | 2021 |
ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
Topics: Adenosine Triphosphate; Breast Neoplasms; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Quaternary Ammonium Compounds | 2021 |
Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Cell Proliferation; Doxorubicin; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyesters; Prodrugs; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
PEGPH20 May Improve Standard-of-Care Therapy in Pancreatic Cancer.
Topics: Adenocarcinoma; Albumins; Breast Neoplasms; Deoxycytidine; Gemcitabine; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Paclitaxel; Pancreatic Neoplasms | 2018 |
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Injections, Subcutaneous; Middle Aged; Mouth Diseases; Mouth Mucosa; Pemphigus; Treatment Outcome | 2018 |
Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy.
Topics: A549 Cells; Animals; Breast Neoplasms; Cell Line, Tumor; Female; HSP70 Heat-Shock Proteins; Humans; Hyaluronoglucosaminidase; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2019 |
Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis.
Topics: Animals; B7-H1 Antigen; Biomimetic Materials; Breast Neoplasms; Cations; Cell Death; Cell Line, Tumor; Endocytosis; Female; Gold; Humans; Hyaluronoglucosaminidase; Immunotherapy; Lung Neoplasms; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Paclitaxel; Particle Size; Peptides; RAW 264.7 Cells; Reactive Oxygen Species; Tissue Distribution | 2019 |
Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.
Topics: Animals; Blotting, Western; Breast Neoplasms; Calcium; Cell Movement; Disease Progression; Endoplasmic Reticulum; Epithelial-Mesenchymal Transition; Fluorescence Recovery After Photobleaching; Fluorescence Resonance Energy Transfer; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hyaluronoglucosaminidase; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Protein Kinase C-alpha; Proteins; Signal Transduction; Spectrometry, Fluorescence; Up-Regulation | 2013 |
Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hyaluronoglucosaminidase; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Proteins; Proteomics | 2014 |
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cell Adhesion Molecules; CpG Islands; DNA Methylation; Early Detection of Cancer; Female; Genetic Predisposition to Disease; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; Middle Aged; Oligonucleotide Array Sequence Analysis; Young Adult | 2015 |
Hyaluronidase-1 expression promotes lung metastasis in syngeneic mouse tumor models without affecting accumulation of small hyaluronan oligosaccharides in tumor interstitial fluid.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Extracellular Fluid; Hyaluronic Acid; Hyaluronoglucosaminidase; Lung Neoplasms; Mice | 2015 |
A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Extracellular Matrix; Female; Glucuronosyltransferase; GPI-Linked Proteins; Histone Acetyltransferases; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; MCF-7 Cells; Middle Aged; Molecular Weight; Neoplasm Invasiveness; Up-Regulation | 2015 |
Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Drug Delivery Systems; Endosomes; Gene Transfer Techniques; Humans; Hyaluronoglucosaminidase; Mice; Snake Venoms; TNF-Related Apoptosis-Inducing Ligand; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells.
Topics: Binding Sites; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Chromosomes, Human, Pair 3; Databases, Genetic; Down-Regulation; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; MCF-7 Cells; Multigene Family; Promoter Regions, Genetic; Sp1 Transcription Factor | 2016 |
Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Breast Neoplasms; Cohort Studies; Female; Gene Expression; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Middle Aged; Neoplasm Grading; Neoplasm Staging; RNA, Messenger | 2017 |
Modulating Three-Dimensional Microenvironment with Hyaluronan of Different Molecular Weights Alters Breast Cancer Cell Invasion Behavior.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Molecular Weight; Neoplasm Proteins; Tumor Microenvironment | 2017 |
Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Enzyme Stability; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Scorpion Venoms; Scorpions; Temperature | 2008 |
Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Topics: Breast Neoplasms; Cathepsin D; Cell Line, Tumor; Humans; Hyaluronoglucosaminidase; Immunohistochemistry; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Estrogen; Vascular Endothelial Growth Factor A | 2009 |
HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Adhesion; Cell Movement; Cell Proliferation; Disease Progression; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hyaluronoglucosaminidase; Immunoenzyme Techniques; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured; Umbilical Veins; Xenograft Model Antitumor Assays | 2011 |
[Effects of SiRNA-EGFR on the expression of hyaluronidase gene EGFR in human breast cancer cells].
Topics: Breast Neoplasms; Cell Line, Tumor; ErbB Receptors; Female; Humans; Hyaluronoglucosaminidase; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transfection | 2010 |
Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells.
Topics: Animals; Bacteriophages; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunoblotting; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Neoplasm Invasiveness; Oligosaccharides; rhoA GTP-Binding Protein | 2010 |
Gene expression of O-GlcNAc cycling enzymes in human breast cancers.
Topics: Acetylglucosamine; Adult; Aged; Antigens, Neoplasm; Breast Neoplasms; Enzyme Activation; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Lymph Nodes; Middle Aged; N-Acetylglucosaminyltransferases; Neoplasm Grading; RNA, Messenger; Statistics, Nonparametric | 2012 |
Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Female; Flow Cytometry; Humans; Hyaluronoglucosaminidase; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NIH 3T3 Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Umbilical Veins; Up-Regulation; Wound Healing | 2011 |
Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer.
Topics: Base Sequence; Breast Neoplasms; DNA; Epigenesis, Genetic; Female; Gene Silencing; Humans; Hyaluronoglucosaminidase; Molecular Sequence Data; Promoter Regions, Genetic; Proteins; Real-Time Polymerase Chain Reaction; Sequence Homology, Nucleic Acid; Transcription, Genetic | 2012 |
Bioactive hyaluronan fragment (hexasaccharide) detects specific hexa-binding proteins in human breast and stomach cancer: possible role in tumorogenesis.
Topics: Breast Neoplasms; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Oligosaccharides; Receptors, Cell Surface; Stomach Neoplasms; Substrate Specificity | 2012 |
[Inverse effects of hyaluronidase and antihyaluronidase serum on the development of mammary carcinoma in the mouse].
Topics: Animals; Antibodies; Breast Neoplasms; Humans; Hyaluronoglucosaminidase; Immune Sera; Mice; Neoplasms, Experimental | 1957 |
[Effect of spreading factors on the development of mouse mammary carcinoma].
Topics: Animals; Breast; Breast Neoplasms; Humans; Hyaluronoglucosaminidase; Mice; Neoplasms, Experimental; Polysaccharide-Lyases; Venoms | 1957 |
CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Topics: Amides; Amiloride; Animals; Breast Neoplasms; Cathepsin B; Caveolin 1; Caveolins; Cell Line, Tumor; Endosomes; Enzyme Inhibitors; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Immunoglobulin G; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Microdomains; Membrane Proteins; Neoplasm Invasiveness; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Rats; rho-Associated Kinases; RNA, Small Interfering; Sodium-Hydrogen Exchangers | 2004 |
[Expression of PH20 in primary and metastatic breast cancer and its pathological significance].
Topics: Adenocarcinoma, Mucinous; Adult; Animals; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Adhesion Molecules; Female; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Rabbits; RNA, Messenger | 2004 |
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Topics: Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Glucuronosyltransferase; Glycocalyx; GPI-Linked Proteins; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Isoenzymes; Molecular Weight; Neoplasm Invasiveness; RNA, Messenger; Up-Regulation | 2005 |
Upregulation of the KIAA1199 gene is associated with cellular mortality.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Division; Cell Transformation, Neoplastic; Cellular Senescence; Chromosomes, Human, Pair 3; Female; Fibroblasts; Gene Expression Regulation; Humans; Hyaluronoglucosaminidase; Kidney Neoplasms; Male; Prostatic Neoplasms; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2006 |
Hypoxia-induced alterations in hyaluronan and hyaluronidase.
Topics: Acetylglucosaminidase; Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Breast Neoplasms; Cell Line, Tumor; Female; Fibrosarcoma; Histone Acetyltransferases; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hypoxia; Mice; Mice, Inbred C3H; Molecular Weight; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic | 2005 |
[Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells].
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Genetic Therapy; Humans; Hyaluronoglucosaminidase; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transfection | 2006 |
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Isoenzymes; Neoplasm Invasiveness; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transfection | 2007 |
Mucolytic enzyme systems; relationship of hyaluronidase inhibition by blood serum to incidence of mammary cancer in mice.
Topics: Animals; Breast Neoplasms; Expectorants; Hematologic Neoplasms; Humans; Hyaluronoglucosaminidase; Incidence; Mice; Neoplasms; Serum | 1948 |
Molecular risk assessment for breast cancer development in patients with ductal hyperplasias.
Topics: Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gene Expression; Humans; Hyaluronoglucosaminidase; Hyperplasia; Immunohistochemistry; Precancerous Conditions; Predictive Value of Tests; Retrospective Studies; Risk Assessment; ROC Curve | 2008 |
Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
Topics: Alternative Splicing; Amino Acid Sequence; Base Sequence; Blotting, Southern; Breast Neoplasms; Cloning, Molecular; DNA, Neoplasm; Female; Genetic Variation; Humans; Hyaluronoglucosaminidase; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Receptors, Lymphocyte Homing; Tumor Cells, Cultured | 1993 |
Increased hyaluronidase levels in breast tumor metastases.
Topics: Breast Neoplasms; Female; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Neoplasm Proteins; Tumor Cells, Cultured | 1997 |
[Radiation-induced morphea].
Topics: Breast Neoplasms; Female; Humans; Hyaluronoglucosaminidase; Middle Aged; PUVA Therapy; Scleroderma, Localized; X-Rays | 1999 |
The affinity of MCF7 breast cancer cells to hyaluronan substrates of different molecular weight and concentrations in an in vitro model.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Adhesion; Cell Aggregation; Cells, Cultured; Female; Fibroblasts; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Microscopy, Electron, Scanning; Molecular Weight; Osmolar Concentration; Tumor Cells, Cultured | 2000 |
Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer.
Topics: Adenocarcinoma; Animals; Breast; Breast Neoplasms; Enzyme Induction; Female; Gene Expression Profiling; Genes; Humans; Hyaluronoglucosaminidase; Male; Mice; Mice, Nude; Multigene Family; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Organ Specificity; Prostatic Neoplasms; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Subcellular Fractions; Testis; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Expression of PH-20 in normal and neoplastic breast tissue.
Topics: Biomarkers, Tumor; Black People; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Adhesion Molecules; Female; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Neoplasm Invasiveness; Prognosis; Racial Groups; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2002 |
[Promotion of growth of human breast cancer cells MDA231 by human sperm membrane-bound hyaluronidase: an experimental study].
Topics: Animals; Aorta; Breast Neoplasms; Cattle; Cell Division; Chick Embryo; Disease Models, Animal; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Membrane Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Spermatozoa; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma.
Topics: Adenocarcinoma, Mucinous; Breast Neoplasms; Carcinoma in Situ; Epithelial Cells; Female; Humans; Hyaluronoglucosaminidase; Mucins; Neuraminidase | 1975 |
Host-tumor relationship. XXXIV. Hyaluronidase activity and hyaluronidase inhibitor in the serum of patients with malignant tumors.
Topics: Breast Neoplasms; Chromatography, Gel; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Hyaluronoglucosaminidase; Lung Neoplasms; Melanoma; Neoplasms | 1977 |
Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Chemotherapy, Adjuvant; Doxorubicin; Drug Synergism; Female; Humans; Hyaluronoglucosaminidase; Mammary Neoplasms, Experimental; Mice | 1992 |